Submitted on Friday 10th June 2016
Published on Thursday 30th June 2016
Current status: Closed
Closed: Friday 30th December 2016
Signatures: 635
Parliament to modify a rule* that stops the NHS from saving money on a drug.
This is a unique situation. One Swiss pharmaceutical company makes 2 very similar medicines: ranibizumab, known by its trade name Lucentis, and bevacizumab ( Avastin). However Lucentis is 80 times more expensive than Avastin.
Research has shown that both drugs can prevent blindness equally.
NHS patients with age-related macular degeneration took part in the IVAN study in 2008.
The MHRA's Guidance Note 14 specifically prohibits* obtaining a licensed special medicine in order to save money.
The appropriateness of this sanction when applied to the unique circumstance of Lucentis & Avastin merits parliamentary debate to change this law.
https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/373505/The_supply_of_unlicensed_medicinal_products__specials_.pdf
You can't sign this petition because it is now closed. But you can still comment on it here at Repetition.me!
52.14.85.76 Sat, 27 Apr 2024 05:06:41 +0100
